These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 11023454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA, Elkins KL, Merchlinsky MJ, Weir JP.
    J Infect Dis; 2002 Oct 15; 186(8):1065-73. PubMed ID: 12355355
    [Abstract] [Full Text] [Related]

  • 3. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
    Higgins TJ, Herold KM, Arnold RL, McElhiney SP, Shroff KE, Pachuk CJ.
    J Infect Dis; 2000 Nov 15; 182(5):1311-20. PubMed ID: 11023455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
    Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.
    J Infect Dis; 2005 Dec 15; 192(12):2117-23. PubMed ID: 16288376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M, Soleimanjahi H, Fotouhi F, Pakravan N.
    Comp Immunol Microbiol Infect Dis; 2009 Sep 15; 32(5):453-61. PubMed ID: 18571235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
    Quenelle DC, Collins DJ, Marciani DJ, Kern ER.
    Vaccine; 2006 Mar 06; 24(10):1515-22. PubMed ID: 16288820
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A, Merigan TC.
    J Immunol; 1988 Jan 01; 140(1):294-9. PubMed ID: 2826591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
    Liu XJ, Zhu MZ, Song GX, Xu YF, Liu HW, Wang S, Yang BL, Dong FT, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 01; 27(1):67-72. PubMed ID: 15782496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.